ArticleFrontiers in immunology2024

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma.

Kangqiang Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.